Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Efficacy of Cidofovir in Treatment of BK Virus Induced Hemorrhagic Cystitis in Post Allogeneic Hematopoietic Cell Transplant Recipients

Eric Anthony Coomes, MD, Amanda Jacques, BScPharm, RPh, ACPR, Fotios V. Michelis, MD PhD, Dennis (Dong-Hwong) Kim, MD PhD, Santhosh Thyagu, MD, Auro Viswabandya, MDMDcine,DM Clinical Hematology, Jeff H. Lipton, MD PhD, Hans A. Messner, MD PhD, Uday Deotare, MD

Blood (2017) 130 (Supplement 1): 5479.

https://doi.org/10.1182/blood.V130.Suppl_1.5479.5479

Published: 2017

Journal Articles

Early HHV-6 Reactivation in CMV-Seronegative Cord Blood Transplant Recipients Is Associated with Inferior Relapse-Free and Overall Survival

Armin Rashidi, MD PhD, Maryam Ebadi, MD, Bassil Said, MD, Qing Cao, M.S., Jeffrey S. Miller, MD, Daniel J. Weisdorf, MD

Blood (2017) 130 (Supplement 1): 1935.

https://doi.org/10.1182/blood.V130.Suppl_1.1935.1935

Published: 2017

Journal Articles

Patients with Central Nervous System Lymphoma Undergoing Thiotepa, Busulfan, and Cyclophosphamide-Conditioned Autologous Stem Cell Transplantation Are at a Higher Risk for DNA Virus Infections Than Patients with Systemic Non-Hodgkin Lymphoma Receiving Traditional Conditioning

Michael Scordo, MD, Sejal M. Morjaria, MD, Ankush Bhatia, MD, Eric R. Littmann, BA, Molly Maloy, MS, Lisa DeAngelis, MD, Sergio A. Giralt, MD, Ying Taur, MD MPH, Craig S. Sauter, MD

Blood (2017) 130 (Supplement 1): 4528.

https://doi.org/10.1182/blood.V130.Suppl_1.4528.4528

Published: 2017

Journal Articles

Detection of Multiple Double-Stranded DNA Viruses after Cord Blood Transplantation Is Frequent and Persistent

Joshua A Hill, MD, Bryan T Mayer, PhD, Hu Xie, MSc, Wendy M Leisenring, PhD, Filippo Milano, MD PhD, Colleen Delaney, MD MSc, Meei-Li Huang, PhD, Terry L Stevens-Ayers, MS, Keith R Jerome, MD PhD, Garrett Nichols, MD MS, Danielle M Zerr, MD MPH, Joshua T Schiffer, MD MS, Michael Boeckh, MD

Blood (2015) 126 (23): 3104.

https://doi.org/10.1182/blood.V126.23.3104.3104

Published: 2015

Journal Articles

Romidepsin in Relapsed/Refractory HTLV-1 Associated Adult T-Cell Lymphoma/Leukemia: A Case Series

Nikhil Mukhi, MD, Vaibhav Verma, MBBS, Anam Ahmed, MD, Hana Lim, MD, Jason Gonsky, MD PhD, Gurinder Sidhu, MD

Blood (2015) 126 (23): 5113.

https://doi.org/10.1182/blood.V126.23.5113.5113

Published: 2015

Journal Articles

Adoptive T Cell Therapy for Polyomaviral Infections and Related Diseases

Dhana Chinnasamy, PhD, Greg Whitehill, BS, Keyvan Keyvanfar, BS, Isaac Brownell, MD PhD, Christopher Buck, PhD, Pawel Muranski, MD, Austin John Barrett, MDFRCP,FRCPath

Blood (2015) 126 (23): 4294.

https://doi.org/10.1182/blood.V126.23.4294.4294

Published: 2015

Journal Articles

The New Prognostic Model Using Whole Blood Epstein-Barr Virus-DNA Positivity and Low Absolute Lymphocyte Count in Patients with Primary Central Nerve System Lymphoma

Ji Eun Jang, MD, Soo Jeong Kim, MD, June-Won Cheong, MD, PhD, Yun Deok Kim, MD, Yu Ri Kim, MD,PhD, Yoo Hong Min, MD,PhD, Jin Seok Kim, MD, PhD

Blood (2014) 124 (21): 3014.

https://doi.org/10.1182/blood.V124.21.3014.3014

Published: 2014

Journal Articles

BK Virus (BKV) Associated Haemorrhagic Cystitis Is Associated with Graft Versus Host Disease (GVHD) and Significant Morbidity Post Haematopoietic Stem Cell Transplant (HSCT).

Alesia Abigael Hunt, MBChB MRCP, Anjum Bashir Khan, MBChB, MRCP, Donal McLornan, MD, PhD, Majid A Kazmi, BmedBiol MB ChB MRCP(UK) MRCPath, Matthew Streetly, BMBS, MRCP, MRCPath, Victor Noriega, MD, Eithne MacMahon, Kavita Raj, MD, PhD, MRCP, FRCPath

Blood (2012) 120 (21): 3040.

https://doi.org/10.1182/blood.V120.21.3040.3040

Published: 2012

Journal Articles

Identification of a Novel Inhibitor That Selectively Targets NF-κB Activity in KSHV-Infected Lymphoma Cells

Utthara Nayar, PhD, Gunkut Akar, Robert H Shoemaker, PhD, Shizuko Sei, MD, Ethel Cesarman, MD, PhD

Blood (2012) 120 (21): 160.

https://doi.org/10.1182/blood.V120.21.160.160

Published: 2012

Journal Articles

Herpesvirus-Associated Central Nervous System Diseases After Allogeneic Hematopoietic Stem Cell Transplantation

Qifa Liu, M.D., Meiqing Wu, Fen Huang, M.D., Zhiping Fan, Hongsheng Zhou, Qianli Jiang, Yu Zhang, Ke Zhao, Li Xuan, Xiao Zhai, Fuhua Zhang, Changxin Yin, Jing Sun, Ru Feng, M.D.

Blood (2012) 120 (21): 4139.

https://doi.org/10.1182/blood.V120.21.4139.4139

Published: 2012

Journal Articles

High Margin of Pathogen Safety for a Plasma-Derived FXIII Concentrate for the Treatment of Congenital FXIII Deficiency

Albrecht Groener, Thomas Nowak, Birgit Popp, Wolfram Schäfer

Blood (2011) 118 (21): 4655.

https://doi.org/10.1182/blood.V118.21.4655.4655

Published: 2011

Journal Articles

Multiple Dedicated Measures Result in a Plasma-Derived FVIII Concentrate with High Margin of Safety Regarding Pathogen Transmission

Albrecht Groener, Thomas Nowak, Birgit Popp, Wolfram Schäfer

Blood (2011) 118 (21): 4355.

https://doi.org/10.1182/blood.V118.21.4355.4355

Published: 2011

Journal Articles

Results of a Phase I-II Clinical Trial of Oxaliplatin, Fludarabine, Cytarabine, and Rituximab (OFAR) Combination Therapy In Patients with Aggressive, Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) and Richter Syndrome (RS)

Apostolia Maria Tsimberidou, MD, PhD, William G. Wierda, MD, PhD, Sijin Wen, Ph.D., William Plunkett, PhD, Susan O'Brien, MD, Thomas J. Kipps, MD, PhD, Jeffrey A. Jones, MD, MPH, Hagop M. Kantarjian, Michael J. Keating, MD

Blood (2010) 116 (21): 923.

https://doi.org/10.1182/blood.V116.21.923.923

Published: 2010

Journal Articles

Effect of CMX001 on Levels of DNA Virus In Patients After Allogeneic Stem Cell Transplantation.

Don A. Gabriel, MD, PhD, Julia Whitley, BS, Kamakshi Rao, PharmD, Charles van der Horst, MD, Jonathan Serody, MD, James Coghill, MD, Stefanie Sarantopoulos, MD, PhD, Paul Armistead, MD, PhD, William Wood, MD, MPH, Thomas C. Shea, MD

Blood (2010) 116 (21): 4550.

https://doi.org/10.1182/blood.V116.21.4550.4550

Published: 2010

Journal Articles

Both Naïve and Memory T-Cell Subsets Participate in Alloresponses to HLA-Mismatched Targets – Implications for Adoptive Transfer of Viral Antigen-Specific T Cells.

J. Joseph Melenhorst, Ph.D., Phillip Scheinberg, MD, Ann Williams, Keyvan Keyvanfar, Melody Smith, J. Philip McCoy, Jr., PhD, Nancy F. Hensel, A. John Barrett, MD

Blood (2009) 114 (22): 2439.

https://doi.org/10.1182/blood.V114.22.2439.2439

Published: 2009

Journal Articles

Oxaliplatin, Fludarabine, Cytarabine, and Rituximab Combination Therapy Induces High Response Rates in Agressive Chronic Lymphocytic Leukemia (CLL) and Richter's Syndrome (RS).

Apostolia-Maria Tsimberidou, MD, PhD, William Wierda, MD, PhD, William Plunkett, Susan O'Brien, M.D., Thomas J. Kipps, MD, PhD, Jeffrey Alan Jones, MD, MPH, Susan Smith, Annette Jalayer, RN, Hagop M. Kantarjian, MD, Michael Keating, MD

Blood (2009) 114 (22): 3443.

https://doi.org/10.1182/blood.V114.22.3443.3443

Published: 2009

Journal Articles

Profound Shut-Down of Antigen Specific T-Cell Effector Functions by Dasatinib.

Ralf Weichsel, Carolin Dix, Linda Wooldrige, BVSc MSc DPhil MRCVS, Matthew Clement, BSc, Angharad Fenton-May, DPhil, Josef Zezula, PhD, Elisabeth Greiner, PhD, Emma Gostick, BSc MSc, David A. Price, MD DPhil, Hermann Einsele, MD, Ruth Seggewiss, MD

Blood (2007) 110 (11): 1348.

https://doi.org/10.1182/blood.V110.11.1348.1348

Published: 2007

Journal Articles

Inactivation of Pathogens in Red Blood Cells by a Modified Treatment Process Utilizing S-303 and Glutathione.

L. Sawyer, R. Mababangloob, N. Patel, J. Kinsey, A. Sampson-Johannes, D. Hanson

Blood (2006) 108 (11): 4144.

https://doi.org/10.1182/blood.V108.11.4144.4144

Published: 2006

Journal Articles

Combination of Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Richter’s Syndrome and Fludarabine-Refractory Chronic Lymphocytic Leukemia.

Apostolia-Maria Tsimberidou, MD, PhD, William G. Wierda, M.D., Ph.D., Susan O’Brien, M.D., William W. Plunkett, M.D., Thomas J. Kipps, M.D., Jennifer R. Brown, M.D., Ph.D, Susan Lerner, M.S., Hagop Kantarjian, M.D., Michael J. Keating, M.D.

Blood (2006) 108 (11): 2825.

https://doi.org/10.1182/blood.V108.11.2825.2825

Published: 2006

Journal Articles

Oxaliplatin as Single Agent or in Combination in Chronic Lymphocytic Leukaemia (CLL).

Marco Montillo, MD, Sara Miqueleiz, MD, Alessandra Tedeschi, MD, Francesca Ricci, MD, Alfredo Molteni, MD, Enrica Morra, MD

Blood (2006) 108 (11): 4982.

https://doi.org/10.1182/blood.V108.11.4982.4982

Published: 2006

NARROW

Efficacy of Cidofovir in Treatment of BK Virus Induced Hemorrhagic Cystitis in Post Allogeneic Hematopoietic Cell Transplant Recipients

Early HHV-6 Reactivation in CMV-Seronegative Cord Blood Transplant Recipients Is Associated with Inferior Relapse-Free and Overall Survival

Patients with Central Nervous System Lymphoma Undergoing Thiotepa, Busulfan, and Cyclophosphamide-Conditioned Autologous Stem Cell Transplantation Are at a Higher Risk for DNA Virus Infections Than Patients with Systemic Non-Hodgkin Lymphoma Receiving Traditional Conditioning

Detection of Multiple Double-Stranded DNA Viruses after Cord Blood Transplantation Is Frequent and Persistent

Romidepsin in Relapsed/Refractory HTLV-1 Associated Adult T-Cell Lymphoma/Leukemia: A Case Series

Adoptive T Cell Therapy for Polyomaviral Infections and Related Diseases

The New Prognostic Model Using Whole Blood Epstein-Barr Virus-DNA Positivity and Low Absolute Lymphocyte Count in Patients with Primary Central Nerve System Lymphoma

BK Virus (BKV) Associated Haemorrhagic Cystitis Is Associated with Graft Versus Host Disease (GVHD) and Significant Morbidity Post Haematopoietic Stem Cell Transplant (HSCT).

Identification of a Novel Inhibitor That Selectively Targets NF-κB Activity in KSHV-Infected Lymphoma Cells

Herpesvirus-Associated Central Nervous System Diseases After Allogeneic Hematopoietic Stem Cell Transplantation

High Margin of Pathogen Safety for a Plasma-Derived FXIII Concentrate for the Treatment of Congenital FXIII Deficiency

Multiple Dedicated Measures Result in a Plasma-Derived FVIII Concentrate with High Margin of Safety Regarding Pathogen Transmission

Results of a Phase I-II Clinical Trial of Oxaliplatin, Fludarabine, Cytarabine, and Rituximab (OFAR) Combination Therapy In Patients with Aggressive, Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) and Richter Syndrome (RS)

Effect of CMX001 on Levels of DNA Virus In Patients After Allogeneic Stem Cell Transplantation.

Both Naïve and Memory T-Cell Subsets Participate in Alloresponses to HLA-Mismatched Targets – Implications for Adoptive Transfer of Viral Antigen-Specific T Cells.

Oxaliplatin, Fludarabine, Cytarabine, and Rituximab Combination Therapy Induces High Response Rates in Agressive Chronic Lymphocytic Leukemia (CLL) and Richter's Syndrome (RS).

Profound Shut-Down of Antigen Specific T-Cell Effector Functions by Dasatinib.

Inactivation of Pathogens in Red Blood Cells by a Modified Treatment Process Utilizing S-303 and Glutathione.

Combination of Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Richter’s Syndrome and Fludarabine-Refractory Chronic Lymphocytic Leukemia.

Oxaliplatin as Single Agent or in Combination in Chronic Lymphocytic Leukaemia (CLL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only